---
title: è‹¯å·´æ¯”å¦¥
description: 
published: true
date: 2026-01-26T06:57:00.805Z
tags: translated_from_psychonautwiki,freeodwikiæ˜¯ä¸€ä¸ªä»¥å¼€æºå…±äº«ä¸ºå®—æ—¨ï¼Œæä¾›æœ‰å…³odã€overdoseã€è¯ç‰©æ»¥ç”¨ã€å¸æ¯’ã€æ¯’å“ç­‰è¯é¢˜çš„é¡¹ç›®ã€‚
editor: markdown
dateCreated: 2026-01-24T22:15:30.405Z
---

[â—€è¿”å›](./home.md)

# è‹¯å·´æ¯”å¦¥ (Phenobarbital)

<mark>è´¨é‡ä¸é”™ï¼Œä¸è¿‡ä»ç„¶å¿½ç•¥äº†æ–‡æ¡£é“¾æ¥è¿™ä¸€é—®é¢˜ï¼Œæ…ç‚¹</mark>

![Skull and crossbones darktextred2.png](/æ–‡ä»¶/Skull_and_crossbones_darktextred2.png)

**å½“[å·´æ¯”å¦¥ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/å·´æ¯”å¦¥ç±»è¯ç‰©.md)ä¸[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ï¼ˆå¦‚[é˜¿ç‰‡ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)ã€[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/ç²¾ç¥è¯ç†å­¦/è‹¯äºŒæ°®å“ç±»è¯ç‰©.md)ã€[åŠ å·´å–·ä¸ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/åŠ å·´å–·ä¸ç±»è¯ç‰©.md)ã€[å™»å©äºŒæ°®å“ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/å™»å©äºŒæ°®å“ç±»è¯ç‰©.md)ã€[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)æˆ–å…¶ä»–[GABAèƒ½ç‰©è´¨](/ç²¾ç¥è¯ç†å­¦/GABA.md)ï¼‰è”ç”¨æ—¶ï¼Œå¯èƒ½ä¼šå¯¼è‡´æ­»äº¡ã€‚[\[1\]](#cite_note-tripsit-1)**

å¼ºçƒˆå»ºè®®ä¸è¦åŒæ—¶æœç”¨[ä¸­ç­‰](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md)è‡³[ä¸¥é‡](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md)å‰‚é‡çš„è¿™äº›ç‰©è´¨ã€‚

è¯·å‹¿ä¸[æˆŠå·´æ¯”å¦¥](/è¯ç‰©/æˆŠå·´æ¯”å¦¥.md)æ··æ·†ã€‚

| è‹¯å·´æ¯”å¦¥ (Phenobarbital) | |
| --- | --- |
| [![Phenobarbital.svg](/æ–‡ä»¶/Phenobarbital.svg)](/æ–‡ä»¶/Phenobarbital.svg) | |
| **åŒ–å­¦å‘½å** | |
| é€šç”¨å | *Phenobarbital, Phenobarbitone, Luminal, Phenobarb* |
| ç³»ç»Ÿå‘½å | *5-Ethyl-5-phenyl-1,3-diazinane-2,4,6-trione* |
| **åˆ†ç±»** | |
| ç²¾ç¥æ´»æ€§åˆ†ç±» | *[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)* |
| åŒ–å­¦åˆ†ç±» | *[å·´æ¯”å¦¥ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/å·´æ¯”å¦¥ç±»è¯ç‰©.md)* |
| **[ç»™è¯é€”å¾„](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/ç»™è¯é€”å¾„.md)** | **[å£æœ](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/ç»™è¯é€”å¾„.md)** |
| **è­¦å‘Šï¼š** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œä¸ªäººæ•æ„Ÿæ€§çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»è¾ƒä½å‰‚é‡å¼€å§‹ã€‚[å‚è§ä¼¤å®³å‡å°‘æªæ–½](/å…³äºæœ¬ç«™/è§‚å‰æé†’.md)ã€‚ | |
| **[å‰‚é‡](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md)** | |
| [é˜ˆå€¼](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md) | 25 mg |
| [è½»å¾®](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md) | 50 - 100 mg |
| [ä¸­ç­‰](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md) | 100 - 150 mg |
| [å¼ºçƒˆ](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md) | 150 - 300 mg |
| [ä¸¥é‡](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md) | 300 mg + |
| **[æ—¶é•¿](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md)** | |
| [æ€»æ—¶é•¿](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 4 - 6 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 15 - 60 åˆ†é’Ÿ |
| [è¯æ•ˆä¸Šå‡](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 1 - 2 å°æ—¶ |
| [è¯æ•ˆè¾¾å³°](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 4 - 6 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 12 - 24 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/æ—¶é•¿.md) | 1 - 48 å°æ—¶ |
| **å…è´£å£°æ˜ï¼š** æ­¤å¤„çš„[å‰‚é‡](/æ–‡æ¡£/ç²¾ç¥è¯ç†å­¦/å‰‚é‡.md)ä¿¡æ¯ä»…ä¾›æ•™è‚²ç›®çš„ï¼Œæ”¶é›†è‡ªç”¨æˆ·å’Œ[ç½‘ç»œèµ„æº](/å…³äºæœ¬ç«™/home.md)ã€‚å®ƒä¸æ˜¯æ¨èï¼Œåº”ä¸å…¶ä»–æ¥æºæ ¸å®ä»¥ç¡®ä¿å‡†ç¡®æ€§ã€‚ | |
| **[è¯ç‰©è”ç”¨](#Dangerous_interactions)** | âš ï¸ æ…ç”¨ / ğŸ’” å±é™© / â›” ç¦æ­¢ |

**è‹¯å·´æ¯”å¦¥**ï¼ˆPhenobarbitalï¼Œè‹±å¼è‹±è¯­ä¸­ä¹Ÿç§°ä¸º **phenobarbitone**ï¼Œå•†å“åä¸º **é²ç±³é‚£ (Luminal)**ï¼‰æ˜¯ä¸€ç§é•¿æ•ˆçš„[å·´æ¯”å¦¥ç±»](/è¯ç‰©åˆ†ç±»/å·´æ¯”å¦¥ç±»è¯ç‰©.md)ç²¾ç¥æ´»æ€§è¯ç‰©ï¼Œå…·æœ‰å¼ºå¤§çš„æŠ—ç„¦è™‘ã€å‚¬çœ ã€è‚Œè‚‰æ¾å¼›å’Œé—å¿˜æ•ˆåº”ã€‚è‹¯å·´æ¯”å¦¥åœ¨åŒ»å­¦ä¸Šç”¨ä½œ[æŠ—æƒŠå¥è¯](/è¯æ•ˆ/ç™«ç—«å‘ä½œæŠ‘åˆ¶.md)ï¼Œå¶å°”ä¹Ÿç”¨äºçŸ­æœŸæ²»ç–—[å¤±çœ ](/è¯æ•ˆ/é•‡é™.md)ã€‚è‹¯å·´æ¯”å¦¥çš„ä½œç”¨æ–¹å¼ä¸[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/ç²¾ç¥è¯ç†å­¦/è‹¯äºŒæ°®å“ç±»è¯ç‰©.md)ç›¸ä¼¼ï¼Œä½†å·´æ¯”å¦¥ç±»è¯ç‰©ç»“åˆäºGABA-Aå—ä½“ä¸Šä¸€ä¸ªç‹¬ç‰¹çš„å˜æ„ä½ç‚¹ã€‚

ä¸å…¶ä»–å·´æ¯”å¦¥ç±»è¯ç‰©ï¼ˆå¦‚[æˆŠå·´æ¯”å¦¥](/è¯ç‰©/æˆŠå·´æ¯”å¦¥.md)ï¼‰ç›¸æ¯”ï¼Œè‹¯å·´æ¯”å¦¥çš„æ¶ˆé™¤ææ…¢ä¸”ä½œç”¨æŒç»­æ—¶é—´é•¿ï¼Œç±»ä¼¼äº[åœ°è¥¿æ³®](/è¯ç‰©/åœ°è¥¿æ³®.md)ï¼Œè¿™ä½¿å…¶æˆä¸ºæ²»ç–—ç™«ç—«çš„ç†æƒ³é€‰æ‹©ã€‚

åƒå¤§å¤šæ•°é•¿æ•ˆå·´æ¯”å¦¥ç±»è¯ç‰©ä¸€æ ·ï¼Œè‹¯å·´æ¯”å¦¥å¯è¢«è§†ä¸ºå…·æœ‰ä¸­åº¦æˆç˜¾æ€§ã€‚ä¾èµ–è€…çªç„¶åœç”¨è‹¯å·´æ¯”å¦¥å¯èƒ½ä¼šå±åŠç”Ÿå‘½ï¼Œå¯¼è‡´[ç™«ç—«å‘ä½œ](/è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)ç”šè‡³æ­»äº¡[\[2\]](#cite_note-2)ã€‚è‹¯å·´æ¯”å¦¥ä¼šæ€¥å‰§å¢å¼ºå…¶ä»–[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ï¼ˆå¦‚[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)ï¼‰çš„æ•ˆæœï¼ŒåŒæ—¶ä½¿ç”¨å¯èƒ½å¯¼è‡´[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ï¼Œç”šè‡³å¯èƒ½è‡´æ­»ã€‚

æ ¹æ®è®¸å¤šæ¥æºï¼Œå®ƒçš„æ•ˆåŠ›å¤§å¤§å¼ºäºå…¶åŒç±»ç‰©è´¨æˆŠå·´æ¯”å¦¥æˆ–[å¸å¯å·´æ¯”å¦¥](/è¯ç‰©/å¸å¯å·´æ¯”å¦¥.md)[\[3\]](#cite_note-3)'[\[4\]](#cite_note-4)'[\[5\]](#cite_note-5)ï¼Œå…¶ç­‰æ•ˆæŠ‘åˆ¶ä½œç”¨çš„å‰‚é‡æ¢ç®—æ¯”ä¸º1:3ã€‚å°½ç®¡å¦‚æ­¤ï¼Œè¯¥äº§å“ä»ä½œä¸ºæŠ—ç™«ç—«ç‰©è´¨è¢«ä»¥éå¸¸é«˜çš„å‰‚é‡æœç”¨ï¼Œ[æ°¯ç¡è¥¿æ³®](/è¯ç‰©/æ°¯ç¡è¥¿æ³®.md)ä¹Ÿæ˜¯å¦‚æ­¤ï¼Œä½†åœ¨è¿™ç§æƒ…å†µä¸‹ï¼Œæ°¯ç¡è¥¿æ³®å·²åœ¨å¾ˆå¤§ç¨‹åº¦ä¸Šå–ä»£äº†è‹¯å·´æ¯”å¦¥ã€‚

ç›®å½•
--------

* [1 åŒ–å­¦](#Chemistry)
* [2 è¯ç†å­¦](#Pharmacology)
* [3 ä¸»è§‚æ•ˆåº”](#Subjective_effects)
    + [3.1 **èº¯ä½“æ•ˆåº”**](#Physical_effects)
    + [3.2 **è§†è§‰æ•ˆåº”**](#Visual_effects)
    + [3.3 **è®¤çŸ¥æ•ˆåº”**](#Cognitive_effects)
    + [3.4 ä½“éªŒæŠ¥å‘Š](#Experience_reports)
* [4 æ¯’æ€§ä¸ä¼¤å®³æ½œèƒ½](#Toxicity_and_harm_potential)
    + [4.1 è€å—æ€§ä¸æˆç˜¾æ½œèƒ½](#Tolerance_and_addiction_potential)
    + [4.2 å±é™©çš„è¯ç‰©è”ç”¨](#Dangerous_interactions)
    + [4.3 è¯ç‰©è¿‡é‡](#Overdose)
* [5 æ³•å¾‹åœ°ä½](#Legal_status)
* [6 å¦è§](#See_also)
* [7 å¤–éƒ¨é“¾æ¥](#External_links)
* [8 å‚è€ƒæ–‡çŒ®](#References)

åŒ–å­¦
---------

è‹¯å·´æ¯”å¦¥å±äº[å·´æ¯”å¦¥ç±»](/è¯ç‰©åˆ†ç±»/å·´æ¯”å¦¥ç±»è¯ç‰©.md)è¯ç‰©ã€‚å·´æ¯”å¦¥ç±»è¯ç‰©å«æœ‰å·´æ¯”å¦¥é…¸çš„éª¨æ¶ã€‚è‹¯å·´æ¯”å¦¥åœ¨å·´æ¯”å¦¥é…¸éª¨æ¶çš„5ä½ä¸Šæœ‰ä¸€ä¸ª5-ä¹™åŸºå’Œ5-è‹¯åŸºå–ä»£åŸºï¼Œè¿™èµ‹äºˆäº†å®ƒç‹¬ç‰¹çš„è¯ç†ä½œç”¨ã€‚è‹¯å·´æ¯”å¦¥çš„å®éªŒå¼ä¸ºC12H12N2O3ï¼Œæ‘©å°”è´¨é‡ä¸º232.235å…‹/æ‘©å°”ã€‚

è‹¯å·´æ¯”å¦¥è¡¨ç°ä¸ºæ— è‡­çš„ç™½è‰²ç»“æ™¶ç²‰æœ«æˆ–æ— è‰²æ™¶ä½“ã€‚é¥±å’Œæ°´æº¶æ¶²å¯¹çŸ³è•Šå‘ˆé…¸æ€§ï¼ˆpHå€¼çº¦ä¸º5ï¼‰ã€‚å‘³å¾®è‹¦ã€‚[\[6\]](#cite_note-6) è‹¯å·´æ¯”å¦¥é’ çš„æ°´æº¶æ¶²é€šå¸¸ä¸ç¨³å®šã€‚è¯¥è¯ç‰©åœ¨èšä¹™äºŒé†‡æˆ–ä¸™äºŒé†‡ä¸­æ›´ç¨³å®šã€‚[\[7\]](#cite_note-7)

è¯ç†å­¦
------------

å·´æ¯”å¦¥ç±»è¯ç‰©çš„è¡Œä¸ºç±»ä¼¼äº[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/ç²¾ç¥è¯ç†å­¦/è‹¯äºŒæ°®å“ç±»è¯ç‰©.md)ã€‚è‹¯å·´æ¯”å¦¥ç»“åˆäºGABA-Aå—ä½“çš„ä¸€ä¸ªå˜æ„ä½ç‚¹ï¼Œå¢å¼ºå†…æºæ€§é…ä½“[Î³-æ°¨åŸºä¸é…¸ (GABA)](/ç²¾ç¥è¯ç†å­¦/GABA.md)çš„ä½œç”¨ã€‚å½“å·´æ¯”å¦¥ç±»è¯ç‰©ä¸GABA-Aå—ä½“ç»“åˆæ—¶ï¼Œä¼šå¯¼è‡´ç¦»å­é€šé“å¼€æ”¾æ—¶é—´å»¶é•¿ï¼Œä»è€Œå¢åŠ ç»†èƒå†…æ°¯ç¦»å­çš„æµ“åº¦ã€‚ç”±äºè¯¥ä½ç‚¹æ˜¯å¤§è„‘ä¸­æœ€é«˜äº§çš„æŠ‘åˆ¶æ€§å—ä½“ç»„ï¼Œå…¶è°ƒèŠ‚å¯¼è‡´äº†å·´æ¯”å¦¥ç±»è¯ç‰©å¯¹ç¥ç»ç³»ç»Ÿçš„[é•‡é™](/è¯æ•ˆ/é•‡é™.md)ï¼ˆæˆ–[å¹³é™æ•ˆåº”](/è¯æ•ˆ/ç„¦è™‘æŠ‘åˆ¶.md)ï¼‰ã€‚è‹¯å·´æ¯”å¦¥çš„ç”Ÿç‰©åŠè¡°æœŸä¸º53-118å°æ—¶ã€‚å®ƒç”±è‚è„ä»£è°¢ï¼Œå¹¶ç”±è‚¾è„å’Œè‚ é“æ’æ³„ã€‚

è‹¯å·´æ¯”å¦¥çš„å£æœç”Ÿç‰©åˆ©ç”¨åº¦çº¦ä¸º90%ã€‚å£æœç»™è¯å8è‡³12å°æ—¶è¾¾åˆ°è¡€æµ†å³°å€¼æµ“åº¦ï¼ˆCmaxï¼‰ã€‚å®ƒæ˜¯å¯ç”¨çš„ä½œç”¨æ—¶é—´æœ€é•¿çš„å·´æ¯”å¦¥ç±»è¯ç‰©ä¹‹ä¸€â€”â€”å®ƒåœ¨ä½“å†…çš„åœç•™æ—¶é—´éå¸¸é•¿ï¼ˆåŠè¡°æœŸä¸º2è‡³7å¤©ï¼‰ï¼Œä¸”è›‹ç™½ç»“åˆç‡æä½ï¼ˆ20%è‡³45%ï¼‰ã€‚è‹¯å·´æ¯”å¦¥ç”±è‚è„ä»£è°¢ï¼Œä¸»è¦é€šè¿‡ç¾ŸåŸºåŒ–å’Œè‘¡è„ç³–é†›é…¸åŒ–ï¼Œå¹¶è¯±å¯¼ç»†èƒè‰²ç´ P450ç³»ç»Ÿçš„è®¸å¤šåŒå·¥é…¶ã€‚ç»†èƒè‰²ç´ P450 2B6 (CYP2B6) ç‰¹åˆ«ç”±è‹¯å·´æ¯”å¦¥é€šè¿‡CAR/RXRæ ¸å—ä½“å¼‚äºŒèšä½“è¯±å¯¼ã€‚å®ƒä¸»è¦ç”±è‚¾è„æ’æ³„ã€‚[\[8\]](#cite_note-8)

ä¸»è§‚æ•ˆåº”
------------------

***å…è´£å£°æ˜ï¼š** ä¸‹åˆ—æ•ˆåº”å¼•ç”¨è‡ª[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](/è¯æ•ˆ/home.md) (**SEI**)ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ[PsychonautWiki](/å…³äºæœ¬ç«™/home.md)è´¡çŒ®è€…ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”å¸¦ç€å¥åº·çš„æ€€ç–‘æ€åº¦æ¥çœ‹å¾…å®ƒä»¬ã€‚*

*åŒæ ·å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡è¾ƒé«˜çš„å‰‚é‡æ›´å¯èƒ½è¯±å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚åŒæ ·ï¼Œ**ä¸è‰¯ååº”**éšç€å‰‚é‡çš„å¢åŠ è€Œå˜å¾—è¶Šæ¥è¶Šå¯èƒ½ï¼Œå¹¶å¯èƒ½åŒ…æ‹¬**æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡*** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”** ![Child.svg](/æ–‡ä»¶/Child.svg)

*     + **[é•‡é™](/è¯æ•ˆ/é•‡é™.md)** - åœ¨èƒ½é‡æ°´å¹³æ”¹å˜æ–¹é¢ï¼Œè¯¥è¯ç‰©å…·æœ‰æå¼ºçš„é•‡é™ä½œç”¨ï¼Œé€šå¸¸å¯¼è‡´ä¸€ç§å‹å€’æ€§çš„å—œç¡çŠ¶æ€ã€‚åœ¨è¾ƒé«˜æ°´å¹³ä¸‹ï¼Œè¿™ä¼šå¯¼è‡´ä½¿ç”¨è€…çªç„¶æ„Ÿè§‰æåº¦ç¡çœ ä¸è¶³ï¼Œå¥½åƒå‡ å¤©æ²¡ç¡ä¸€æ ·ï¼Œè¿«ä½¿ä»–ä»¬åä¸‹ï¼Œé€šå¸¸æ„Ÿè§‰éšæ—¶å¤„äºæ˜å¥çš„è¾¹ç¼˜ï¼Œè€Œä¸æ˜¯ä»äº‹ä½“è‚²æ´»åŠ¨ã€‚è¿™ç§ç¡çœ ä¸è¶³æ„Ÿä¸å‰‚é‡æˆæ­£æ¯”ï¼Œæœ€ç»ˆå˜å¾—è¶³å¤Ÿå¼ºå¤§ï¼Œè¿«ä½¿äººå®Œå…¨å¤±å»çŸ¥è§‰ã€‚
    + **[è¿åŠ¨æ§åˆ¶ä¸§å¤±](/è¯æ•ˆ/è¿åŠ¨æ§åˆ¶ä¸§å¤±.md)**
    + **[è‚Œè‚‰æ¾å¼›](/è¯æ•ˆ/è‚Œè‚‰æ¾å¼›.md)**
    + **[å¤´æ™•](/è¯æ•ˆ/å¤´æ™•.md)**
    + **[è¡€å‹é™ä½](/è¯æ•ˆ/è¡€å‹é™ä½.md)** - å·´æ¯”å¦¥ç±»è¯ç‰©å¯èƒ½ä¼šé™ä½æŸäº›äººçš„è¡€å‹ï¼Œå¶å°”ä¹Ÿè¢«ç”¨äºé™ä½é¢…å†…å‹ã€‚[\[9\]](#cite_note-9)
    + **[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)**
    + **[ç™«ç—«å‘ä½œæŠ‘åˆ¶](/è¯æ•ˆ/ç™«ç—«å‘ä½œæŠ‘åˆ¶.md)**
    + **[èº¯ä½“æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)** - ä¸çŸ­æ•ˆå·´æ¯”å¦¥ç±»è¯ç‰©å¦‚[æˆŠå·´æ¯”å¦¥](/è¯ç‰©/æˆŠå·´æ¯”å¦¥.md)å’Œ[å¸å¯å·´æ¯”å¦¥](/è¯ç‰©/å¸å¯å·´æ¯”å¦¥.md)ç›¸æ¯”ï¼Œè¿™ç§æ•ˆåº”ç›¸å½“å¾®å¼±ã€‚
    + **[æ€§æ¬²å‡é€€](/è¯æ•ˆ/æ€§æ¬²å‡é€€.md)**

### **è§†è§‰æ•ˆåº”** ![Eye.svg](/æ–‡ä»¶/Eye.svg)

*     + **[è§†è§‰é”åº¦æŠ‘åˆ¶](/è¯æ•ˆ/è§†è§‰é”åº¦æŠ‘åˆ¶.md)** - åƒè®¸å¤š[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ä¸€æ ·ï¼Œé«˜å‰‚é‡çš„è‹¯å·´æ¯”å¦¥å¯èƒ½ä¼šå¯¼è‡´è§†åŠ›æ¨¡ç³Šã€‚

### **è®¤çŸ¥æ•ˆåº”** ![User.svg](/æ–‡ä»¶/User.svg)

*     + **[ç„¦è™‘æŠ‘åˆ¶](/è¯æ•ˆ/ç„¦è™‘æŠ‘åˆ¶.md)**
    + **[è®¤çŸ¥æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/è®¤çŸ¥æ¬£å¿«æ„Ÿ.md)** - ä¸çŸ­æ•ˆå·´æ¯”å¦¥ç±»è¯ç‰©å¦‚[æˆŠå·´æ¯”å¦¥](/è¯ç‰©/æˆŠå·´æ¯”å¦¥.md)å’Œ[å¸å¯å·´æ¯”å¦¥](/è¯ç‰©/å¸å¯å·´æ¯”å¦¥.md)ç›¸æ¯”ï¼Œè¿™ç§æ•ˆåº”ç›¸å½“å¾®å¼±ã€‚è¿™ç§æ„Ÿè§‰æœ¬èº«å¯ä»¥æè¿°ä¸ºä¸€ç§æåº¦å¼ºçƒˆçš„æ”¾æ¾æ»¡è¶³æ„Ÿã€‚
    + **[æ€ç»´å‡ç¼“](/è¯æ•ˆ/æ€ç»´å‡ç¼“.md)**
    + **[åˆ†æèƒ½åŠ›æŠ‘åˆ¶](/è¯æ•ˆ/åˆ†æèƒ½åŠ›æŠ‘åˆ¶.md)**
    + **[å»æŠ‘åˆ¶](/è¯æ•ˆ/å»æŠ‘åˆ¶.md)**
    + **[å¥å¿˜](/è¯æ•ˆ/å¥å¿˜.md)**
    + **[è¯­è¨€èƒ½åŠ›æŠ‘åˆ¶](/è¯æ•ˆ/è¯­è¨€èƒ½åŠ›æŠ‘åˆ¶.md)** - åœ¨è¾ƒé«˜å‰‚é‡ä¸‹ï¼Œå·²çŸ¥è‹¯å·´æ¯”å¦¥ä¼šå¯¼è‡´è¨€è¯­ä¸æ¸…ã€‚
    + **[å¼ºè¿«æ€§é‡å¤ç”¨è¯](/è¯æ•ˆ/å¼ºè¿«æ€§é‡å¤ç”¨è¯.md)**
    + **[æƒ…æ„ŸæŠ‘åˆ¶](/è¯æ•ˆ/æƒ…æ„ŸæŠ‘åˆ¶.md)** - å°½ç®¡è¯¥åŒ–åˆç‰©ä¸»è¦æŠ‘åˆ¶ç„¦è™‘ï¼Œä½†å®ƒä¹Ÿä¼šä»¥ä¸€ç§ç‹¬ç‰¹ä½†ä¸åƒ[æŠ—ç²¾ç¥ç—…è¯](/è¯ç‰©åˆ†ç±»/æŠ—ç²¾ç¥ç—…è¯.md)é‚£ä¹ˆå¼ºçƒˆçš„æ–¹å¼è¿Ÿé’åŒ–å…¶ä»–æƒ…ç»ªã€‚
    + **[æ¸…é†’é”™è§‰](/è¯æ•ˆ/å¦„æƒ³.md)** - è¿™æ˜¯ä¸€ç§é”™è¯¯çš„ä¿¡å¿µï¼Œå³å°½ç®¡æœ‰æ˜æ˜¾çš„è¯æ®è¡¨æ˜ç›¸åï¼ˆå¦‚ä¸¥é‡çš„è®¤çŸ¥éšœç¢å’Œæ— æ³•ä¸ä»–äººå……åˆ†äº¤æµï¼‰ï¼Œä½†è®¤ä¸ºè‡ªå·±å®Œå…¨æ¸…é†’ã€‚è¿™æœ€å¸¸å‘ç”Ÿåœ¨ä¸¥é‡å‰‚é‡ä¸‹ã€‚

### ä½“éªŒæŠ¥å‘Š

ç›®å‰åœ¨æˆ‘ä»¬çš„[ä½“éªŒç´¢å¼•](/å…³äºæœ¬ç«™/home.md)ä¸­æ²¡æœ‰æè¿°è¯¥åŒ–åˆç‰©æ•ˆåº”çš„è½¶äº‹æŠ¥å‘Šã€‚æ›´å¤šçš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

* [Erowid Experience Vaults: Phenobarbital](https://erowid.org/experiences/subs/exp_Barbiturates_Phenobarbital.shtml)


æ¯’æ€§ä¸ä¼¤å®³æ½œèƒ½
---------------------------

[![Harmchart.png](/æ–‡ä»¶/Harmchart.png)](/æ–‡ä»¶/Harmchart.png)

é›·è¾¾å›¾æ˜¾ç¤ºäº†å·´æ¯”å¦¥ç±»è¯ç‰©ä¸å…¶ä»–è¯ç‰©ç›¸æ¯”çš„ç›¸å¯¹èº«ä½“ä¼¤å®³ã€ç¤¾ä¼šä¼¤å®³å’Œä¾èµ–æ€§ã€‚[\[10\]](#cite_note-10)

è‹¯å·´æ¯”å¦¥ç›¸å¯¹äºå‰‚é‡å¯èƒ½å…·æœ‰ä¸­ç­‰æ¯’æ€§ã€‚ç„¶è€Œï¼Œå½“ä¸[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)å¦‚[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)æˆ–[é˜¿ç‰‡ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)æ··åˆæ—¶ï¼Œè‹¯å·´æ¯”å¦¥å…·æœ‰æ½œåœ¨çš„[è‡´æ­»æ€§](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€‚ä¸å…¶ä»–è¯ç‰©ï¼ˆå¦‚è‹¯äºŒæ°®å“ç±»è¯ç‰©ï¼‰ç›¸æ¯”ï¼Œè‹¯å·´æ¯”å¦¥ä¸[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)åŒæ—¶ä½¿ç”¨ç›¸å…³çš„æ­»äº¡æˆ–ä¸¥é‡ä¸è‰¯ååº”é£é™©æ›´é«˜ã€‚å·²æœ‰ç ”ç©¶å°†ä½¿ç”¨å·´æ¯”å¦¥ç±»è¯ç‰©ï¼Œç‰¹åˆ«æ˜¯è‹¯å·´æ¯”å¦¥ï¼Œä¸ç™Œç—‡çš„å‘å±•è”ç³»èµ·æ¥[\[11\]](#cite_note-11)ã€‚

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨è¯¥è¯ç‰©æ—¶é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/å…³äºæœ¬ç«™/è§‚å‰æé†’.md)ã€‚

### è€å—æ€§ä¸æˆç˜¾æ½œèƒ½

è‹¯å·´æ¯”å¦¥å…·æœ‰æå¼ºçš„ç”Ÿç†å’Œå¿ƒç†æˆç˜¾æ€§ã€‚å·´æ¯”å¦¥ç±»è¯ç‰©æˆ’æ–­åœ¨åŒ»å­¦ä¸Šæ˜¯ä¸¥é‡çš„ï¼Œå¯èƒ½ä¼šå¯¼è‡´å±åŠç”Ÿå‘½çš„æˆ’æ–­ç»¼åˆå¾ï¼Œå¼•å‘[ç™«ç—«å‘ä½œ](/è¯æ•ˆ/ç™«ç—«å‘ä½œ.md)ã€[ç²¾ç¥ç—…](/è¯æ•ˆ/ç²¾ç¥ç—….md)å’Œæ­»äº¡ã€‚åœ¨æˆ’æ–­æœŸé—´åº”é¿å…ä½¿ç”¨é™ä½ç™«ç—«é˜ˆå€¼çš„è¯ç‰©ï¼Œå¦‚[æ›²é©¬å¤š](/è¯ç‰©/æ›²é©¬å¤š.md)å’Œ[è‹¯ä¸™èƒº](/è¯ç‰©/è‹¯ä¸™èƒº.md)ã€‚

é•¿æœŸä½¿ç”¨åä¼šå¯¹è‹¯å·´æ¯”å¦¥çš„é•‡é™å‚¬çœ ä½œç”¨äº§ç”Ÿè€å—æ€§ã€‚å°šä¸æ¸…æ¥šè€å—æ€§æ¢å¤åˆ°åŸºçº¿ç©¶ç«Ÿéœ€è¦å¤šé•¿æ—¶é—´ã€‚è‹¯å·´æ¯”å¦¥ä¸æ‰€æœ‰å·´æ¯”å¦¥ç±»è¯ç‰©å‡å­˜åœ¨äº¤å‰è€å—æ€§ï¼Œè¿™æ„å‘³ç€åœ¨æœç”¨å®ƒä¹‹åï¼Œæ‰€æœ‰å·´æ¯”å¦¥ç±»è¯ç‰©çš„æ•ˆæœéƒ½ä¼šé™ä½ã€‚

### å±é™©çš„è¯ç‰©è”ç”¨

å°½ç®¡è®¸å¤šè¯ç‰©å•ç‹¬ä½¿ç”¨æ˜¯å®‰å…¨çš„ï¼Œä½†å½“ä¸å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶ï¼Œå®ƒä»¬å¯èƒ½ä¼šå˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä¸‹è¡¨åŒ…å«ä¸€äº›å¸¸è§çš„æ½œåœ¨å±é™©ç»„åˆï¼Œä½†å¯èƒ½ä¸åŒ…æ‹¬æ‰€æœ‰ç»„åˆã€‚æŸäº›ç»„åˆåœ¨ä½å‰‚é‡ä¸‹å¯èƒ½æ˜¯æ— å®³çš„ï¼Œä½†ä»ä¼šå¢åŠ æ­»äº¡çš„æ½œåœ¨é£é™©ã€‚åœ¨æœç”¨å‰ï¼Œåº”å§‹ç»ˆè¿›è¡Œ[ç‹¬ç«‹ç ”ç©¶](https://www.google.com/)ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆæ˜¯å®‰å…¨çš„ã€‚

* **[æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)** (*[1,4-ä¸äºŒé†‡](/è¯ç‰©/1,4-ä¸äºŒé†‡.md), [2-ç”²åŸº-2-ä¸é†‡](/è¯ç‰©/2-ç”²åŸº-2-ä¸é†‡.md), [é…’ç²¾](/è¯ç‰©/é…’ç²¾.md), [å·´æ¯”å¦¥ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/å·´æ¯”å¦¥ç±»è¯ç‰©.md), [GHB](/è¯ç‰©/GHB.md)/[GBL](/è¯ç‰©/GBL.md), [ç”²å–¹é…®](/è¯ç‰©/ç”²å–¹é…®.md), [é˜¿ç‰‡ç±»è¯ç‰©](/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)*) - è¿™ç§ç»„åˆå¯èƒ½å¯¼è‡´å±é™©ç”šè‡³è‡´å‘½ç¨‹åº¦çš„[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€‚è¿™äº›ç‰©è´¨ä¼šå¢å¼ºå½¼æ­¤å¼•èµ·çš„[è‚Œè‚‰æ¾å¼›](/è¯æ•ˆ/è‚Œè‚‰æ¾å¼›.md)ã€[é•‡é™](/è¯æ•ˆ/é•‡é™.md)å’Œ[å¥å¿˜](/è¯æ•ˆ/å¥å¿˜.md)ï¼Œå¹¶å¯èƒ½åœ¨é«˜å‰‚é‡ä¸‹å¯¼è‡´æ„å¤–çš„æ„è¯†ä¸§å¤±ã€‚åœ¨æ„è¯†ä¸§å¤±æœŸé—´å‘•åçš„é£é™©ä¹Ÿä¼šå¢åŠ ï¼Œå¹¶å¯èƒ½å› éšåçš„çª’æ¯è€Œæ­»äº¡ã€‚å¦‚æœå‘ç”Ÿè¿™ç§æƒ…å†µï¼Œä½¿ç”¨è€…åº”å°è¯•ä»¥[å¤åŸä½“ä½](/æ–‡æ¡£/è¯ç‰©åº”å¯¹æªæ–½/BLSï¼ˆåŸºæœ¬ç”Ÿå‘½ç»´æŒæœ¯ï¼‰.md)å…¥ç¡ï¼Œæˆ–è®©æœ‹å‹å°†å…¶ç§»åŠ¨åˆ°è¯¥ä½“ä½ã€‚
* **[è§£ç¦»å‰‚](/è¯ç‰©åˆ†ç±»/è§£ç¦»å‰‚.md)** - è¿™ç§ç»„åˆå¯èƒ½å¯¼è‡´åœ¨æ„è¯†ä¸§å¤±æœŸé—´å‘•åçš„é£é™©å¢åŠ ï¼Œå¹¶å¯èƒ½å› éšåçš„çª’æ¯è€Œæ­»äº¡ã€‚å¦‚æœå‘ç”Ÿè¿™ç§æƒ…å†µï¼Œä½¿ç”¨è€…åº”å°è¯•ä»¥[å¤åŸä½“ä½](/æ–‡æ¡£/è¯ç‰©åº”å¯¹æªæ–½/BLSï¼ˆåŸºæœ¬ç”Ÿå‘½ç»´æŒæœ¯ï¼‰.md)å…¥ç¡ï¼Œæˆ–è®©æœ‹å‹å°†å…¶ç§»åŠ¨åˆ°è¯¥ä½“ä½ã€‚
* **[å…´å¥‹å‰‚](/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)** - å°†å·´æ¯”å¦¥ç±»è¯ç‰©ä¸[å…´å¥‹å‰‚](/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md)ç»“åˆæ˜¯ä¸å®‰å…¨çš„ï¼Œå› ä¸ºå­˜åœ¨è¿‡åº¦ä¸­æ¯’çš„é£é™©ã€‚å…´å¥‹å‰‚ä¼šé™ä½å·´æ¯”å¦¥ç±»è¯ç‰©çš„[é•‡é™](/è¯æ•ˆ/é•‡é™.md)ä½œç”¨ï¼Œè€Œè¿™æ˜¯å¤§å¤šæ•°äººåœ¨ç¡®å®šå…¶ä¸­æ¯’ç¨‹åº¦æ—¶è€ƒè™‘çš„ä¸»è¦å› ç´ ã€‚ä¸€æ—¦å…´å¥‹å‰‚è¯æ•ˆæ¶ˆé€€ï¼Œå·´æ¯”å¦¥ç±»è¯ç‰©çš„ä½œç”¨å°†æ˜¾ç€å¢å¼ºï¼Œå¯¼è‡´åŠ å‰§çš„[å»æŠ‘åˆ¶](/è¯æ•ˆ/å»æŠ‘åˆ¶.md)ä»¥åŠå…¶ä»–æ•ˆåº”ã€‚å¦‚æœè”ç”¨ï¼Œåº”ä¸¥æ ¼é™åˆ¶æ¯å°æ—¶æœç”¨çš„å·´æ¯”å¦¥ç±»è¯ç‰©çš„é‡ã€‚å¦‚æœä¸ç›‘æµ‹æ°´åˆ†æ‘„å…¥ï¼Œè¿™ç§ç»„åˆè¿˜å¯èƒ½å¯¼è‡´ä¸¥é‡è„±æ°´ã€‚

### è¯ç‰©è¿‡é‡

å½“æœç”¨æå¤§é‡çš„å·´æ¯”å¦¥ç±»è¯ç‰©æˆ–ä¸å…¶ä»–æŠ‘åˆ¶å‰‚åŒæ—¶æœç”¨æ—¶ï¼Œå¯èƒ½ä¼šå‘ç”Ÿå·´æ¯”å¦¥ç±»è¯ç‰©è¿‡é‡ã€‚è¿™åœ¨ä¸å…¶ä»–GABAèƒ½æŠ‘åˆ¶å‰‚ï¼ˆå¦‚[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/ç²¾ç¥è¯ç†å­¦/è‹¯äºŒæ°®å“ç±»è¯ç‰©.md)å’Œ[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)ï¼‰ä¸€èµ·ä½¿ç”¨æ—¶ç‰¹åˆ«å±é™©ï¼Œå› ä¸ºå®ƒä»¬çš„ä½œç”¨æ–¹å¼ç›¸ä¼¼ï¼Œä½†ç»“åˆåœ¨GABA-Aå—ä½“çš„ä¸åŒå˜æ„ä½ç‚¹ä¸Šï¼Œå› æ­¤å®ƒä»¬çš„æ•ˆæœä¼šç›¸äº’å¢å¼ºã€‚è‹¯äºŒæ°®å“ç±»è¯ç‰©å¢åŠ GABA-Aå—ä½“ä¸Šæ°¯ç¦»å­é€šé“å¼€æ”¾çš„é¢‘ç‡ï¼Œè€Œå·´æ¯”å¦¥ç±»è¯ç‰©å¢åŠ å®ƒä»¬å¼€æ”¾çš„æŒç»­æ—¶é—´ï¼Œè¿™æ„å‘³ç€å½“ä¸¤è€…éƒ½è¢«æ¶ˆè€—æ—¶ï¼Œç¦»å­é€šé“å°†æ›´é¢‘ç¹åœ°å¼€æ”¾å¹¶ä¿æŒå¼€æ”¾æ›´é•¿æ—¶é—´[\[12\]](#cite_note-12)ã€‚å·´æ¯”å¦¥ç±»è¯ç‰©è¿‡é‡æ˜¯ä¸€ç§åŒ»ç–—ç´§æ€¥æƒ…å†µï¼Œå¦‚æœä¸åŠæ—¶å’Œé€‚å½“åœ°æ²»ç–—ï¼Œå¯èƒ½å¯¼è‡´æ˜è¿·ã€æ°¸ä¹…æ€§è„‘æŸä¼¤æˆ–æ­»äº¡ã€‚ä¸å…¶ä»–æŠ‘åˆ¶å‰‚ç›¸æ¯”ï¼Œå·´æ¯”å¦¥ç±»è¯ç‰©è¿‡é‡å‘ç”Ÿä¸¥é‡ä¸è‰¯ååº”çš„é¢‘ç‡æ›´é«˜ã€‚

å·´æ¯”å¦¥ç±»è¯ç‰©è¿‡é‡çš„ç—‡çŠ¶å¯èƒ½åŒ…æ‹¬ä¸¥é‡çš„[æ€ç»´å‡ç¼“](/è¯æ•ˆ/æ€ç»´å‡ç¼“.md)ã€[è¨€è¯­ä¸æ¸…](/è¯æ•ˆ/è¯­è¨€èƒ½åŠ›æŠ‘åˆ¶.md)ã€[æ„è¯†æ¨¡ç³Š](/è¯æ•ˆ/æ„è¯†æ¨¡ç³Š.md)ã€[å¦„æƒ³](/è¯æ•ˆ/å¦„æƒ³.md)ã€[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€æ˜è¿·æˆ–æ­»äº¡[\[13\]](#cite_note-13)ã€‚

æ³•å¾‹åœ°ä½
------------

åœ¨å›½é™…ä¸Šï¼Œè‹¯å·´æ¯”å¦¥è¢«åˆ—å…¥è”åˆå›½ã€Šç²¾ç¥è¯ç‰©å…¬çº¦ã€‹é™„è¡¨IVã€‚[\[14\]](#cite_note-14)

* **æ¾³å¤§åˆ©äºš**: è‹¯å·´æ¯”å¦¥è¢«åˆ—å…¥é™„è¡¨4ï¼Œä½¿å…¶æˆä¸ºå¤„æ–¹è¯ã€‚[\[15\]](#cite_note-15)
* **åŠ æ‹¿å¤§**: è‹¯å·´æ¯”å¦¥æ˜¯é™„è¡¨IVç®¡åˆ¶ç‰©è´¨ã€‚[\[16\]](#cite_note-16)
* **å¾·å›½**: è‹¯å·´æ¯”å¦¥å— Anlage III BtMG (*éº»é†‰å“æ³•ï¼Œé™„è¡¨III*) ç®¡åˆ¶ã€‚[\[17\]](#cite_note-BtMG_AnlageIII-17) å®ƒåªèƒ½é€šè¿‡éº»é†‰å“å¤„æ–¹å•å¼€å…·ï¼Œé™¤éåˆ¶å‰‚ä¸­æ¯ç§å‰‚å‹å«æœ‰ä¸è¶…è¿‡10%æˆ–ä¸è¶…è¿‡300æ¯«å…‹çš„è‹¯å·´æ¯”å¦¥ã€‚[\[17\]](#cite_note-BtMG_AnlageIII-17)
* **ä¿„ç½—æ–¯**: è‡ª2013å¹´èµ·ï¼Œè‹¯å·´æ¯”å¦¥æ˜¯é™„è¡¨IIIç®¡åˆ¶ç‰©è´¨ã€‚[\[18\]](#cite_note-18) ä½†è‹¯å·´æ¯”å¦¥ä¹Ÿå­˜åœ¨äºè¯ç‰© [Corvalol](http://en.wikipedia.org/wiki/Corvalol "wikipedia:Corvalol") æˆ– Valocordin ä¸­ï¼Œè¿™äº›è¯ç‰©æ— éœ€åŒ»ç”Ÿå¤„æ–¹å³å¯åˆ†å‘ã€‚[\[19\]](#cite_note-19)
* **ç‘å£«**: è‹¯å·´æ¯”å¦¥æ˜¯ Verzeichnis B ä¸‹ç‰¹åˆ«åˆ—å‡ºçš„ç®¡åˆ¶ç‰©è´¨ã€‚å…è®¸åŒ»ç–—ç”¨é€”ã€‚[\[20\]](#cite_note-20)
* **è‹±å›½**: è‹¯å·´æ¯”å¦¥æ˜¯Bç±»ç®¡åˆ¶ç‰©è´¨ã€‚[\[21\]](#cite_note-21)
* **ç¾å›½**: è‹¯å·´æ¯”å¦¥æ˜¯é™„è¡¨IVç®¡åˆ¶ç‰©è´¨ã€‚[\[22\]](#cite_note-22)

å¦è§
--------

* [æŠ‘åˆ¶å‰‚](/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)
* [è‹¯äºŒæ°®å“ç±»è¯ç‰©](/ç²¾ç¥è¯ç†å­¦/è‹¯äºŒæ°®å“ç±»è¯ç‰©.md)
* [GABA](/ç²¾ç¥è¯ç†å­¦/GABA.md)

å¤–éƒ¨é“¾æ¥
--------------

* [Phenobarbital (Wikipedia)](https://en.wikipedia.org/wiki/Phenobarbital)
* [Phenobarbital (TiHKAL / Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=3991)
* [Phenobarbital (DrugBank)](https://go.drugbank.com/drugs/DB01174)

å‚è€ƒæ–‡çŒ®
----------

1. [â†‘](#cite_ref-tripsit_1-0) [*Risks of Combining Depressants \- TripSit*](https://tripsit.me/combining-depressants/)Â 
2. [â†‘](#cite_ref-2) Sarrecchia, C., Sordillo, P., Conte, G., Rocchi, G. (December 1998). "\[Barbiturate withdrawal syndrome: a case associated with the abuse of a headache medication\]". *Annali Italiani Di Medicina Interna: Organo Ufficiale Della Societa Italiana Di Medicina Interna*. **13** (4): 237â€“239. [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0393-9340](//www.worldcat.org/issn/0393-9340).Â 
3. [â†‘](#cite_ref-3) [*Benzodiazepine Equivalents Conversion Calculator \- ClinCalc.com*](https://clincalc.com/Benzodiazepine/)Â 
4. [â†‘](#cite_ref-4) [*Benzodiazepine Equivalents*](https://fpnotebook.com/psych/cd/BnzdzpnEqvlnts.htm)Â 
5. [â†‘](#cite_ref-5) Inada, T., Inagaki, A. (August 2015). ["Psychotropic dose equivalence in Japan: Psychotropic dose equivalence in Japan"](https://onlinelibrary.wiley.com/doi/10.1111/pcn.12275). *Psychiatry and Clinical Neurosciences*. **69** (8): 440â€“447. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1111/pcn.12275](//doi.org/10.1111%2Fpcn.12275). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1323-1316](//www.worldcat.org/issn/1323-1316).Â 
6. [â†‘](#cite_ref-6) National Toxicology Program, Institute of Environmental Health Sciences, National Institutes of Health (NTP). 1992. National Toxicology Program Chemical Repository Database. Research Triangle Park, North Carolina.
7. [â†‘](#cite_ref-7) Snow, E. K., American Society of Health-System Pharmacists (2009). *AHFS drug information, 2009*. American Society of Health-System Pharmacists. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9781585282272](http://en.wikipedia.org/wiki/Special:BookSources/9781585282272 "wikipedia:Special:BookSources/9781585282272").Â 
8. [â†‘](#cite_ref-8) Flynn, S., Babi, M. A. (2017). "Pharmacology and Therapeutics for Dentistry". [*Anticonvulsants*](https://linkinghub.elsevier.com/retrieve/pii/B9780323393072000126). Elsevier. pp. 176â€“192. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/B978-0-323-39307-2.00012-6](//doi.org/10.1016%2FB978-0-323-39307-2.00012-6). [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9780323393072](http://en.wikipedia.org/wiki/Special:BookSources/9780323393072 "wikipedia:Special:BookSources/9780323393072").Â 
9. [â†‘](#cite_ref-9) Roberts, I., Sydenham, E. (12 December 2012). Cochrane Injuries Group, ed. ["Barbiturates for acute traumatic brain injury"](https://doi.wiley.com/10.1002/14651858.CD000033.pub2). *Cochrane Database of Systematic Reviews*. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/14651858.CD000033.pub2](//doi.org/10.1002%2F14651858.CD000033.pub2). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1465-1858](//www.worldcat.org/issn/1465-1858).Â 
10. [â†‘](#cite_ref-10) Nutt, D., King, L. A., Saulsbury, W., Blakemore, C. (24 March 2007). ["Development of a rational scale to assess the harm of drugs of potential misuse"](https://www.sciencedirect.com/science/article/pii/S0140673607604644). *The Lancet*. **369** (9566): 1047â€“1053. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/S0140-6736(07)60464-4](//doi.org/10.1016%2FS0140-6736%2807%2960464-4). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0140-6736](//www.worldcat.org/issn/0140-6736).Â 
11. [â†‘](#cite_ref-11) Friedman, G. D., Habel, L. A. (1 June 1999). ["Barbiturates and lung cancer: a re-evaluation"](https://academic.oup.com/ije/article-lookup/doi/10.1093/ije/28.3.375). *International Journal of Epidemiology*. **28** (3): 375â€“379. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1093/ije/28.3.375](//doi.org/10.1093%2Fije%2F28.3.375). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0300-5771](//www.worldcat.org/issn/0300-5771).Â 
12. [â†‘](#cite_ref-12) Twyman, R. E., Rogers, C. J., Macdonald, R. L. (March 1989). "Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital". *Annals of Neurology*. **25** (3): 213â€“220. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/ana.410250302](//doi.org/10.1002%2Fana.410250302). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0364-5134](//www.worldcat.org/issn/0364-5134).Â 
13. [â†‘](#cite_ref-13) [*Barbiturate intoxication and overdose: MedlinePlus Medical Encyclopedia*](https://medlineplus.gov/ency/article/000951.htm)Â 
14. [â†‘](#cite_ref-14) UN Convention on Psychotropic Substances | <https://www.unodc.org/documents/commissions/CND/Int_Drug_Control_Conventions/1971_Schedules/Revision1_2015/ST_CND_1_ADD2_Rev1_e_V1600359.pdf>
15. [â†‘](#cite_ref-15) Controlled Drugs | <http://www.health.nsw.gov.au/pharmaceutical/Documents/poisons-list-alpha.pdf>
16. [â†‘](#cite_ref-16) Branch, L. S. (2022), [*Consolidated federal laws of Canada, Controlled Drugs and Substances Act*](https://laws-lois.justice.gc.ca/eng/acts/c-38.8/page-15.html)Â 
17. â†‘ [17.0](#cite_ref-BtMG_AnlageIII_17-0) [17.1](#cite_ref-BtMG_AnlageIII_17-1) ["Anlage III BtMG"](https://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html) (in German). Bundesministerium der Justiz und fÃ¼r Verbraucherschutz. Retrieved December 26, 2019.Â 
18. [â†‘](#cite_ref-18) [*ĞŸĞ¾ÑÑ‚Ğ°Ğ½Ğ¾Ğ²Ğ»ĞµĞ½Ğ¸Ğµ ĞŸÑ€Ğ°Ğ²Ğ¸Ñ‚ĞµĞ»ÑŒÑÑ‚Ğ²Ğ° Ğ Ğ¤ Ğ¾Ñ‚ 04.02.2013 N 78 â€œĞ Ğ²Ğ½ĞµÑĞµĞ½Ğ¸Ğ¸ Ğ¸Ğ·Ğ¼ĞµĞ½ĞµĞ½Ğ¸Ğ¹ Ğ² Ğ½ĞµĞºĞ¾Ñ‚Ğ¾Ñ€Ñ‹Ğµ Ğ°ĞºÑ‚Ñ‹ ĞŸÑ€Ğ°Ğ²Ğ¸Ñ‚ĞµĞ»ÑŒÑÑ‚Ğ²Ğ° Ğ Ğ¾ÑÑĞ¸Ğ¹ÑĞºĞ¾Ğ¹ Ğ¤ĞµĞ´ĞµÑ€Ğ°Ñ†Ğ¸Ğ¸â€ - ĞšĞ¾Ğ½ÑÑƒĞ»ÑŒÑ‚Ğ°Ğ½Ñ‚ĞŸĞ»ÑÑ*](https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=141744&dst=100005&date=02.12.2019)Â 
19. [â†‘](#cite_ref-19) [*Ğ“Ğ¾ÑÑƒĞ´Ğ°Ñ€ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ğ¹ Ñ€ĞµĞµÑÑ‚Ñ€ Ğ»ĞµĞºĞ°Ñ€ÑÑ‚Ğ²ĞµĞ½Ğ½Ñ‹Ñ… ÑÑ€ĞµĞ´ÑÑ‚Ğ²*](https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=fbbb0394-bac0-4f25-820a-a11fed50bbd7&t=)Â 
20. [â†‘](#cite_ref-20) ["Verordnung des EDI Ã¼ber die Verzeichnisse der BetÃ¤ubungsmittel, psychotropen Stoffe, VorlÃ¤uferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.Â 
21. [â†‘](#cite_ref-21) [*Drugs penalties*](https://www.gov.uk/penalties-drug-possession-dealing)Â 
22. [â†‘](#cite_ref-22) DEA Schedule IV Drugs | <https://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf>
